A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers

Evans, Thomas G.; Bonnez, William; O'Brien, Diane; Campbell, Meredith; Rose, Robert C.; Demeter, Lisa; Reichman, Richard C.; Koenig, Scott; Suzich, JoAnn A.; White, Wendy I.; Balsley, James
May 2001
Journal of Infectious Diseases;5/15/2001, Vol. 183 Issue 10, p1485
Academic Journal
Presents information on a study which examined the safety and immunogenicity of a human papillomavirus-11 viruslike particles candidate vaccine in a phase-1, dose-finding trial in humans. Serologic and virologic studies conducted; Statistical methods; Clinical and laboratory toxicity.


Related Articles

  • HPV (HUMAN PAPILLOMAVIRUS) VACCINE.  // Contraceptive Technology Update;Sep2007, Vol. 28 Issue 9, p3 

    The article provides information on the human papillomavirus vaccine, its use and the risks associated with it.

  • Combined support most effective in improving HPV vaccine delivery. Cox, Amber // Infectious Diseases in Children;Aug2013, Vol. 26 Issue 8, p29 

    The article reports on a study published in the journal "Pediatrics," which stated that clinicians and families must collaborate to effectively promote HPV vaccine series receipt.

  • Informe de la autoridad danesa de salud y medicamentos. Chaves-Ortiz, Verónica; Yepes, Francisco; Hernández, Luis Jorge // Revista Gerencia y Políticas de Salud;Jul-Dec2015, Vol. 14 Issue 29, p193 

    No abstract available.

  • Vaccine against HPV infection still under development. Meszaros, Liz // Dermatology Times;Aug96, Vol. 17 Issue 8, p18 

    Reports on researchers' efforts to develop an effective vaccine against human papillomaviruses (HPV). Speech on the issue by physician Lutz Gissmann at the Clinical Dermatology 2000 symposium; Classic vaccination approach to prevent infection; Therapeutic approach to treat existing infection;...

  • safety of HPV vaccine questioned. Pasquali, Kimber // Mothering;Sep/Oct2006, Issue 138, p26 

    The article focuses on the safety issues of a vaccine provided against strains of the human papillomavirus.

  • HPV vaccine 100% effective in those with no prior exposure. Markman MD, Maurie // Hem/Onc Today;12/25/2011, Vol. 12 Issue 24, p19 

    The article reveals the 100 percent efficacy of human papilloma virus (HPV) vaccine when it comes to preventing cervical intraepithelial neoplasia grade 3 or higher in women who have no prior HPV exposure, according to results from the PATRICIA trial.

  • What is next on the HPV vaccine horizon?  // Contraceptive Technology Update;Jun2007, Vol. 28 Issue 6, p65 

    The article offers updates on the development of human papillomavirus (HPV) vaccines in the U.S.

  • Cost-effectiveness study eyes HPV vaccine.  // Contraceptive Technology Update;Nov2008, Vol. 29 Issue 11, p127 

    The article discusses an U.S. analysis which concludes that vaccination human papillomavirus (HPV) will be optimized by achieving universal vaccine coverage in young adolescent girls, targeting initial "catch-up" efforts to vaccinate women younger than age 21, and by revising existing screening...

  • Vaccine to fight cervical cancer available by 2008.  // GP: General Practitioner;11/25/2002, p2 

    Reports on the availability of a vaccine against human papilloma virus (HPV) infection by 2008 in Great Britain. Study conducted in the U.S. to find the effectivity of the HPV vaccine; Use of the vaccine in treatments of cervical cancer.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics